International Immunology, Vol. 11, No. 6, 881-887,
June 1999
© 1999 Japanese Society for Immunology
A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
CREST (Core Research for Evolutional Science and Technology) Project and Department of Molecular Immunology,
1 Department of Developmental Immunology, Graduate School of Medicine, and
2 Department of Obstetrics and Gynaecology, School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
Correspondence to: M Taniguchi
Murine NKT cells can recognize
-galactosylceramide (
-GalCer) in the context of a class Ib CD1d molecule. Here we show that
-GalCer can selectively activate freshly isolated human V
24+Vß11+ cells, functionally defining the human NKT cells. The naive human NKT cell repertoire consisted of cells expressing an invariant V
24J
Q chain and a diverse array of ß chains derived from a single Vß11 gene segment. Stimulation with
-GalCer expanded a polyclonal subset of the human NKT cell repertoire carrying a novel complementarity-determining region (CDR) 3ß consensus motif that may directly interact with the sugar moiety of
-GalCer. Our data suggest that certain redundancy is allowed for CDR3ß of NKT antigen receptor to interact with the ligand and provide a first clue to understand the novel proteincarbohydrate interaction mechanisms.
Keywords: carbohydrate-binding proteins, complementarity-determining region, NKT antigen receptor, proteinsugar interaction, repertoire selection
Transmitting editor: T. Watanabe
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Kjer-Nielsen, N. A. Borg, D. G. Pellicci, T. Beddoe, L. Kostenko, C. S. Clements, N. A. Williamson, M. J. Smyth, G. S. Besra, H. H. Reid, et al. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition J. Exp. Med., March 20, 2006; 203(3): 661 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishikawa, S. Motohashi, E. Ishikawa, H. Fuchida, K. Higashino, M. Otsuji, T. Iizasa, T. Nakayama, M. Taniguchi, and T. Fujisawa A Phase I Study of {alpha}-Galactosylceramide (KRN7000)-Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1910 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Crough, M. Nieda, and A. J. Nicol Granulocyte Colony-Stimulating Factor Modulates {alpha}-Galactosylceramide-Responsive Human V{alpha}24+V{beta}11+ NKT Cells J. Immunol., October 15, 2004; 173(8): 4960 - 4966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skold and S. M. Behar Role of CD1d-Restricted NKT Cells in Microbial Immunity Infect. Immun., October 1, 2003; 71(10): 5447 - 5455. [Full Text] [PDF] |
||||
![]() |
B. Gansuvd, W. J. Hubbard, A. Hutchings, F. T. Thomas, J. Goodwin, S. B. Wilson, M. A. Exley, and J. M. Thomas Phenotypic and Functional Characterization of Long-Term Cultured Rhesus Macaque Spleen-Derived NKT Cells J. Immunol., September 15, 2003; 171(6): 2904 - 2911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ulrichs, D. B. Moody, E. Grant, S. H. E. Kaufmann, and S. A. Porcelli T-Cell Responses to CD1-Presented Lipid Antigens in Humans with Mycobacterium tuberculosis Infection Infect. Immun., June 1, 2003; 71(6): 3076 - 3087. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagisawa, K.-i. Seino, Y. Ishikawa, M. Nozue, T. Todoroki, and K. Fukao Impaired Proliferative Response of V{alpha}24 NKT Cells from Cancer Patients Against {alpha}-Galactosylceramide J. Immunol., June 15, 2002; 168(12): 6494 - 6499. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Metelitsa, O. V. Naidenko, A. Kant, H.-W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells J. Immunol., September 15, 2001; 167(6): 3114 - 3122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kamada, H. Iijima, K. Kimura, M. Harada, E. Shimizu, S.-i. Motohashi, T. Kawano, H. Shinkai, T. Nakayama, T. Sakai, et al. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V{{alpha}}14 NKT cells Int. Immunol., July 1, 2001; 13(7): 853 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kadowaki, S. Antonenko, S. Ho, M.-C. Rissoan, V. Soumelis, S. A. Porcelli, L. L. Lanier, and Y.-J. Liu Distinct Cytokine Profiles of Neonatal Natural Killer T Cells after Expansion with Subsets of Dendritic Cells J. Exp. Med., May 21, 2001; 193(10): 1221 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ronet, M. Mempel, N. Thieblemont, A. Lehuen, P. Kourilsky, and G. Gachelin Role of the Complementarity-Determining Region 3 (CDR3) of the TCR-{{beta}} Chains Associated with the V{{alpha}}14 Semi-Invariant TCR {{alpha}}-Chain in the Selection of CD4+ NK T Cells J. Immunol., February 1, 2001; 166(3): 1755 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Sayers, A. D. Brooks, J. M. Ward, T. Hoshino, W. E. Bere, G. W. Wiegand, J. M. Kelley, and M. J. Smyth The Restricted Expression of Granzyme M in Human Lymphocytes J. Immunol., January 15, 2001; 166(2): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Burdin, L. Brossay, M. Degano, H. Iijima, M. Gui, I. A. Wilson, and M. Kronenberg Structural requirements for antigen presentation by mouse CD1 PNAS, August 29, 2000; 97(18): 10156 - 10161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishihara, M. Nieda, J. Kitayama, T. Osada, T. Yabe, A. Kikuchi, Y. Koezuka, S. A. Porcelli, K. Tadokoro, H. Nagawa, et al. {alpha}-Glycosylceramides Enhance the Antitumor Cytotoxicity of Hepatic Lymphocytes Obtained from Cancer Patients by Activating CD3-CD56+ NK Cells In Vitro J. Immunol., August 1, 2000; 165(3): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. J. van der Vliet, N. Nishi, T. D. de Gruijl, B. M. E. von Blomberg, A. J. M. van den Eertwegh, H. M. Pinedo, G. Giaccone, and R. J. Scheper Human natural killer T cells acquire a memory-activated phenotype before birth Blood, April 1, 2000; 95(7): 2440 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi Augmentation of V{alpha}14 Nkt Cell-Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a-Induced Hepatitis J. Exp. Med., January 3, 2000; 191(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawano, T. Nakayama, N. Kamada, Y. Kaneko, M. Harada, N. Ogura, Y. Akutsu, S. Motohashi, T. Iizasa, H. Endo, et al. Antitumor Cytotoxicity Mediated by Ligand-activated Human V{{alpha}}24 NKT Cells Cancer Res., October 1, 1999; 59(20): 5102 - 5105. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Toura, T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, and M. Taniguchi Cutting Edge: Inhibition of Experimental Tumor Metastasis by Dendritic Cells Pulsed with {alpha}-Galactosylceramide J. Immunol., September 1, 1999; 163(5): 2387 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Matsuda, L. Gapin, N. Fazilleau, K. Warren, O. V. Naidenko, and M. Kronenberg Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size PNAS, October 23, 2001; 98(22): 12636 - 12641. [Abstract] [Full Text] [PDF] |
||||







